The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 28th Oct 2014 09:18

Afren: Credit Suisse lowers target price from 132p to 115p staying with its outperform rating.African Barrick Gold: Westhouse moves target price from 230p to 240p and keeps an add rating.Anglo American: Investec reduces target price from 1603p to 1588p and keeps a buy recommendation.APR Energy: Liberum Capital upgrades to hold with a target price of 385p. Jefferies reduces target price from 1250p to 670p, while its buy recommendation remains unchanged. JP Morgan reduces target price from 1008p to 801p and leaves its overweight rating unchanged.Aviva: Societe Generale raises target price from 580p to 650p maintaining a buy recommendation.Cairn Energy: Credit Suisse cuts target price from 288p to 266p and retains an outperform rating.Croda International: Goldman Sachs reduces target price from 2750p to 2675p, while leaving its buy recommendation unaltered.Direct Line: UBS cuts target price from 304p to 282p and stays with its buy recommendation.Dunelm: Canaccord initiates with a target price of 925p and a buy recommendation.easyJet: Deutsche Bank reduces target price from 1935p to 1830p keeping a buy recommendation.Elementis: Goldman Sachs cuts target price from 345p to 330p and stays with its neutral rating.EnQuest: Credit Suisse cuts target price from 150p to 122p reiterating an outperform rating.Essentra: Goldman Sachs reduces target price from 970p to 880p and retains a buy recommendation.Faroe Petroleum: Credit Suisse lowers target price from 138p to 133p and reiterates a neutral rating.GKN: Westhouse cuts target price from 450p to 400p and leaves its buy recommendation unchanged.GlaxoSmithKline: Jefferies cuts target price from 1400p to 1350p and reiterates a hold recommendation.HSBC Holdings: Deutsche Bank lowers target price from 640p to 638p and retains its hold recommendation.ICAP: Morgan Stanley ups target price from 386p to 408p staying with its equal-weight rating.LSE: Morgan Stanley raises target price from 2098p to 2210p and keeps an overweight rating.Mothercare: JP Morgan cuts target price from 267p to 238p maintaining an overweight rating.Old Mutual: Barclays downgrades to equal-weight with a target price of 205p. JP Morgan shifts target price from 223p to 225p and reiterates an overweight rating.Petra Diamonds: Panmure Gordon cuts target price from 171p to 155p leaving its sell recommendation unchanged.Premier Foods: Societe Generale cuts target price from 70p to 35p and retains its hold recommendation.Premier Oil: Credit Suisse reduces target price from 392p to 355p and reiterates an outperform rating.Shire: Cenkos increases target price from 5200p to 5347p keeping its buy recommendation.SIG: Numis cuts target price from 230p to 200p maintaining its buy recommendation.Standard Chartered: Numis reduces target price from 1400p to 1200p downgrading from add to hold. Investec reduces target price from 1450p to 1350p and stays with its buy recommendation.Stratex: Northland lowers target price from 9.3p to 7.7p and stays with its buy recommendation.Synthomer: Goldman Sachs lowers target price from 260p to 250p and reiterates its neutral rating. Canaccord cuts target price from 283p to 258p and retains a buy recommendation.Tullett Prebon: Morgan Stanley ups target price from 254p to 270p and retains its equal-weight rating.Tullow Oil: Credit Suisse lowers target price from 800p to 790p and keeps a neutral rating.UBM: Canaccord ups target price from 600p to 620p upgrading from hold to buy.Vedanta Resources: Deutsche Bank reduces target price from 1215p to 1180p maintaining a buy recommendation.Victrex: Goldman Sachs reduces target price from 2110p to 2010p and keeps a buy recommendation.Wetherspoon (JD): Numis ups target price from 900p to 950p leaving its add rating unchanged.
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.